Johnson & Johnson (JNJ) Non-cash Items (2010 - 2012)
Johnson & Johnson (JNJ) posted Non-cash Items of $1.0 billion for Q1 2012, up 710570.68% sequentially from $141275.0 in Q1 2011, and up 710570.68% YoY from N/an in Q1 2011.
Johnson & Johnson (JNJ) Non-cash Items (2010 - 2012) Analysis & Trends
Johnson & Johnson (JNJ) has 3 years of Non-cash Items data on file, last reported at $1.0 billion in Q1 2012.
- Quarterly Non-cash Items rose 710570.68% year-over-year to $1.0 billion in Q1 2012, while the trailing twelve-month figure through Jan 2012 was $1.0 billion (up 710570.68% YoY) and the FY2012 annual result came in at $1.0 billion, up 710570.68% from the prior year.
- Non-cash Items advanced to $1.0 billion in Q1 2012 per JNJ's latest filing, from $141275.0 in the prior quarter.
- The five-year high for Non-cash Items was $1.0 billion in Q1 2012, with the low at $141275.0 in Q1 2011.
- Average Non-cash Items over 3 years is $334.8 million, with a median of $148349.0 recorded in 2010.
- Year-over-year, Non-cash Items fell 4.77% in 2011 and jumped 710570.68% in 2012.
- Johnson & Johnson's Non-cash Items stood at $148349.0 in 2010, then decreased by 4.77% to $141275.0 in 2011, then jumped by 710570.68% to $1.0 billion in 2012.
- Business Quant data shows JNJ's Non-cash Items at $1.0 billion in Q1 2012, $141275.0 in Q1 2011, and $148349.0 in Q1 2010.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 1, 2012 | 1.00 Bn |
| Jan 1, 2012 | 1.00 Bn |
| Jan 2, 2011 | 648.00 Mn |
| Jan 2, 2011 | 648.00 Mn |
| Jan 3, 2010 | 1.31 Bn |
| Jan 3, 2010 | 1.31 Bn |